The clinical information you need, at your fingertips.

The approval expands treatment choices for patients who may benefit from clinician-administered biologic therapy. . .

Global forecasts highlight persistent inequities, with deaths nearly doubling in sub-Saharan Africa. . .

New consensus unifies diagnosis, grading, critical care, and transplant decision-making for a high-mortality liver syndrome. . .

Among adults with prediabetes and obesity, GLP-1 receptor agonists were associated with higher rates of normoglycemia and lower risks of diabetes, cardiovascular events, and death. . .

A 52,330-woman study found no increased cardiovascular or clotting risk over an average 12 years of follow-up. . .